ATE339212T1 - Potenzierung der wirksamkeit von sn-38-prodrogen - Google Patents

Potenzierung der wirksamkeit von sn-38-prodrogen

Info

Publication number
ATE339212T1
ATE339212T1 AT00977058T AT00977058T ATE339212T1 AT E339212 T1 ATE339212 T1 AT E339212T1 AT 00977058 T AT00977058 T AT 00977058T AT 00977058 T AT00977058 T AT 00977058T AT E339212 T1 ATE339212 T1 AT E339212T1
Authority
AT
Austria
Prior art keywords
prodrogen
potentiation
effectiveness
prodrug
polyanion
Prior art date
Application number
AT00977058T
Other languages
English (en)
Inventor
Sudhir Agrawal
Original Assignee
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybridon Inc filed Critical Hybridon Inc
Application granted granted Critical
Publication of ATE339212T1 publication Critical patent/ATE339212T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT00977058T 1999-11-09 2000-11-08 Potenzierung der wirksamkeit von sn-38-prodrogen ATE339212T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16418299P 1999-11-09 1999-11-09

Publications (1)

Publication Number Publication Date
ATE339212T1 true ATE339212T1 (de) 2006-10-15

Family

ID=22593346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977058T ATE339212T1 (de) 1999-11-09 2000-11-08 Potenzierung der wirksamkeit von sn-38-prodrogen

Country Status (7)

Country Link
EP (1) EP1229938B1 (de)
JP (1) JP2003513894A (de)
AT (1) ATE339212T1 (de)
AU (1) AU1474901A (de)
CA (1) CA2390975A1 (de)
DE (1) DE60030754T2 (de)
WO (1) WO2001034093A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0796108A2 (de) * 1994-12-06 1997-09-24 Ryan Pharmaceuticals, Inc. Wasser-lösliche ubiquinone-zusammensetzungen, prodroge, und verfahren dembezüglich
GB9801902D0 (en) * 1998-01-29 1998-03-25 Cancer Res Campaign Tech A gene promoter

Also Published As

Publication number Publication date
AU1474901A (en) 2001-06-06
DE60030754T2 (de) 2007-09-20
DE60030754D1 (de) 2006-10-26
JP2003513894A (ja) 2003-04-15
WO2001034093A3 (en) 2001-11-22
CA2390975A1 (en) 2001-05-17
EP1229938A2 (de) 2002-08-14
EP1229938B1 (de) 2006-09-13
WO2001034093A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
BR9807843B1 (pt) heterociclos bicìclicos dissubstituìdos, composições farmacêuticas, uso, bem como processos para preparação das referidas composições e dos referidos compostos.
DK1268481T3 (da) Inaseinkibitorer som terapeutiske midler
NO20014128L (no) Camptothecinderivater som har antitumoraktivitet
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
NO20062548L (no) Intranasale blandinger
AT10109U3 (de) Fentanyl-hältiges, transdermales, therapeutisches system
EA199900912A1 (ru) Фармацевтические средства
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
IT1311921B1 (it) Composti farmaceutici.
WO2001046455A3 (en) Survivin promotion of angiogenesis
DK1268479T3 (da) Phenylsubstituerede indolizinderivater og deres anvendelse som histamin H3-ligander
DE50003566D1 (de) Haftvermittler
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
WO2001030330A3 (en) Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
ITPR20020027A1 (it) Ampolla nebulizzatrice, in particolare per aerosolterapia.
ATE339212T1 (de) Potenzierung der wirksamkeit von sn-38-prodrogen
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
ES1044983Y (es) Aparato de termoestimulacion para tratamientos terapeuticos.
WO2003090674A3 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
NO20050445L (no) Synergistisk interaksjon mellom abacavir og alovudin
BR0210678A (pt) Carbamatos de 2-heterocìclicos-1,2-etanodióis
EE200000179A (et) 1-oxa, aza ja tianaftaleen-2-1 biseetrid fosfolambaani inhibiitoritena
AR030750A1 (es) 1-amino-alquilciclohexanos como agentes tripanocidas
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties